Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon

Infection and Immunity

Volumn 66, Issue 5, 1998, Pages 1962-1967

  Ten Hagen, Timo L M ^a,d   Van Vianen, Wim ^a   Savelkoul, Huub F J ^a   Heremans, Hubertine ^b   Buurman, Wim A ^c   Bakker Woudenberg, Irma A J M ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; PLACEBO; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; ENCAPSULATION; FEMALE; HELPER CELL; HOST RESISTANCE; IMMUNOMODULATION; INTERFERON PRODUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; LYMPHOCYTE DEPLETION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SEPTICEMIA; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

KLEBSIELLA PNEUMONIAE;

EID: 0031946837     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.5.1962-1967.1998     Document Type: Article

References (29)

1. Arase, H., N. Arase, and T. Saito. 1996. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J. Exp. Med. 183:2391-2396.
2. Chan, S. H., M. Kobayashi, D. Santoli, B. Perussia, and G. Tranchieri. 1992. Mechanism of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12). J. Immunol. 148:92-98.
3. Chatelain, R., K. Verkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182-1187.
4. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types mouse helper T cell clones. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays and monoclonal antibodies. J. Exp. Med. 166:1229-1244.
5. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldman. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548-551.
6. D'Andrea, A., M. Rengaraju, N. M. Valiante, et al. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387-1398.
7. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL10) inhibits human lymphocyte Interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041-1048.
8. Dijkmans, R., H. Heremans, and A. Billiau. 1987. Heterogeneity of Chinese hamster ovaria cell-produced recombinant murine interferon-γ. J. Biol. Chem. 262:2528-2535.
9. Fidler, I. J., W. E. Fogler, E. S. Kleinerman, and I. Saiki. 1985. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-γ encapsulated in liposomes. J. Immunol. 135:4289-4296.
10. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444-3451.
11. Heremans, H., R. Dijkmans, H. Sobis, F. Vandekerckhove, and A. Billiau. 1987. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J. Immunol. 138:4175-4179.
12. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
13. Leenen, P. J. M., M. F. T. R. de Bruijn, J. S. A. Voerman, P. A. Campbell, and W. van Ewijk. 1994. Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods 174:5-19.
14. Mehta, K., R. L. Juliano, and G. Lopez-Berestein. 1984. Stimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sites. Immunology 51:517-527.
15. Melissen, P. M. B., W. van Vianen, P. J. M. Leenen, and I. A. J. M. Bakker-Woudenberg. 1994. Tissue distribution and cellular distribution of liposomes encapsulating muramyllripeptide phosphatidyl ethanolamide. Biotherapy 7:71-78.
16. Melissen, P. M. B., W. van Vianen, and I. A. J. M. Bakker-Woudenberg. 1992. Roles of peripheral leukocytes and tissue macrophages in antimicrobial resistance induced by free or liposome-encapsulaled muramyl tripeptide phosphatidylethanolamide. Infect. Immun. 60:2891-2897.
17. Miescher, G. C., M. Schreyer, and H. R. MacDonald. 1989 Production and characterization of a rat monoclonal antibody against the murine CD3 molecular complex. Immunol. Lett. 23:113-118.
18. Moore, K. W., A. O'Gara, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
19. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
20. Mosmann, T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol. 56:1-26.
21. Openshaw, P., E. E. Murphy, N. A. Hosken, V. Maino, K. Davis, K. Murphy, and A. O'Gara. 1995. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1357-1367.
22. Romagnani, S. 1992. Induction of Th1 and Th2 responses: a key role for the 'natural' immune response. Immunol. Today 13:379-381.
23. Savelkoul, H. F. J., R. van Ommen, A. C. T. M. Vossen, E. G. Breedlend, R. L. Coffman, and A. van Oudenaren. 1994. Modulation of systemic cytokine levels by implantation of alginate encapsulated cells. J. Immunol. Methods 170:185-196.
24. Smith, M. R., K. Muegge, J. R. Keller, H.-F. Kung, H. A. Young, and S. K. Durum. 1990. Direct evidence for an intracellular role for IFN-γ: microinjection of human IFN-γ induces Ia expression on murine macrophages. J. Immunol. 144:1777-1782.
25. ten Hagen, T. L. M., W. van Vianen, and I. A. J. M. Bakker-Woudenberg. 1995. Modulation of the non-specific antimicrobial resistance of mice by separate or combined liposome-encapsulated muramyl tripeptide phosphati-dylethanolamine and interferon-γ towards Klebsiella pneumoniae septicemia. J. Infect. Dis. 171:385-392.
26. ten Hagen, T. L. M., W. van Vianen, and I. A. J. M. Bakker-Woudenberg. 1996. Isolation and characterization of murine Kupffer cells and splenic macrophages. J. Immunol. Methods 193:81-91.
27. ten Hagen, T. L. M., W. van Vianen, E. A. T. Straathof, and I. A. J. M. Bakker-Woudenberg. 1994. Effect of liposome-encapsulated muramyl tripeptide phosphatidylethanolamine and interferon gamma on Klebsiella pneumoniae infection in T-cell-defident mice and in vitro, p. 225-234. In K. N. Masihi (ed.), Immunotherapy in infections. Marcel Dekker Inc., New York, N.Y.
28. Tumonari, K. 1988. A rat antibody against a structure functionally related to the mouse T-cell receplor/T3 complex. Immunogenetics 28:455-458.
29. Young, H. A., and K. J. Hardy. 1989. Interferon-γ: producer cells, activation stimuli, and molecular genetic regulation. Pharmacol. Ther. 45:137-151.